James R. Gruber, Chief Financial Officer at Eton Pharmaceuticals, Inc. (ETON), sold 80,795 shares at $16.16 ($1.3M) on 2025-08-19, disclosed to the SEC on 2025-08-20.
Open-market sale of $1.3M ETON by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.16 | 39,082 | $632K | 48.4% |
| 2 | $16.16 | 39,082 | $632K | 48.4% |
| 3 | $16.02 | 2,631 | $42K | 3.2% |
| Total | $16.16 avg | 80,795 | $1.3M | 100% |